These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 31160638

  • 1. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
    Tamura M, Yonezawa T, Liu X, Asada S, Hayashi Y, Fukuyama T, Tanaka Y, Kitamura T, Goyama S.
    Sci Rep; 2019 Jun 03; 9(1):8171. PubMed ID: 31160638
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
    Zhou X, Mei C, Zhang J, Lu Y, Lan J, Lin S, Zhang Y, Kuang Y, Ren Y, Ma L, Wei J, Ye L, Xu W, Li K, Lu C, Jin J, Tong H.
    Hematol Oncol; 2020 Oct 03; 38(4):531-540. PubMed ID: 32469434
    [Abstract] [Full Text] [Related]

  • 3. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ.
    N Engl J Med; 2016 Nov 24; 375(21):2023-2036. PubMed ID: 27959731
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors.
    Ye C, Jiang N, Zheng J, Zhang S, Zhang J, Zhou J.
    Biochim Biophys Acta Rev Cancer; 2024 Mar 24; 1879(2):189066. PubMed ID: 38163523
    [Abstract] [Full Text] [Related]

  • 5. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
    Link PA, Baer MR, James SR, Jones DA, Karpf AR.
    Cancer Res; 2008 Nov 15; 68(22):9358-66. PubMed ID: 19010910
    [Abstract] [Full Text] [Related]

  • 6. Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.
    Mahfouz RZ, Jankowska A, Ebrahem Q, Gu X, Visconte V, Tabarroki A, Terse P, Covey J, Chan K, Ling Y, Engelke KJ, Sekeres MA, Tiu R, Maciejewski J, Radivoyevitch T, Saunthararajah Y.
    Clin Cancer Res; 2013 Feb 15; 19(4):938-48. PubMed ID: 23287564
    [Abstract] [Full Text] [Related]

  • 7. DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents.
    Casellas Román HL, Venugopal K, Feng Y, Shabashvili DE, Posada LM, Li J, Guryanova OA.
    Leuk Res; 2020 Jul 15; 94():106372. PubMed ID: 32445940
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P, Stefanaki K, Rontogianni D, Darivianaki K, Vlychou M, Papadaki E, Eliopoulos G, Bakiri M, Matsouka C, Kakolyris S, Georgoulias V.
    Clin Exp Pathol; 1999 Jul 15; 47(5):231-8. PubMed ID: 10598372
    [Abstract] [Full Text] [Related]

  • 9. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R, Mansat-De Mas V, Gelsi-Boyer V, Demur C, Murati A, Corre J, Prebet T, Bertoli S, Brecqueville M, Arnoulet C, Recher C, Vey N, Mozziconacci MJ, Delabesse E, Birnbaum D.
    Oncotarget; 2015 Apr 10; 6(10):8388-96. PubMed ID: 25860933
    [Abstract] [Full Text] [Related]

  • 10. The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
    Zhang L, McGraw KL, Sallman DA, List AF.
    Leuk Lymphoma; 2017 Aug 10; 58(8):1777-1790. PubMed ID: 27967292
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic evaluation of decitabine for the treatment of leukemia.
    Bryan J, Kantarjian H, Garcia-Manero G, Jabbour E.
    Expert Opin Drug Metab Toxicol; 2011 May 10; 7(5):661-72. PubMed ID: 21500965
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H, Tsushima Y, Nagai K, Yagihashi S.
    Acta Haematol; 2000 May 10; 102(3):115-23. PubMed ID: 10692673
    [Abstract] [Full Text] [Related]

  • 13. Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.
    Wang L, Luo J, Nian Q, Xiao Q, Yang Z, Liu L.
    Hematology; 2014 Jun 10; 19(4):225-31. PubMed ID: 24074450
    [Abstract] [Full Text] [Related]

  • 14. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S, Cai W, Liu Y.
    Curr Opin Hematol; 2022 Jul 01; 29(4):194-200. PubMed ID: 35787548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X, Medeiros LJ, Zhang YH, You MJ, Andreeff M, Konopleva M, Bueso-Ramos CE.
    Clin Lymphoma Myeloma Leuk; 2016 Aug 01; 16 Suppl():S30-8. PubMed ID: 27155969
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.